Market Views – Page 34 – media

Stent Tek Closes Series A Investment Round for its ePATH AVF Device, Aiming to Improve Vascular Access for Hemodialysis

Stent Tek, a medical device company that is developing a minimally invasive catheter system for dialysis patients, announced today it has successfully closed a Series A funding round with investments from two institutional investors.
- Source: infomeddnews
- 413
- September 1, 2017
dialysis Market Views Stent Tek
MedGenome raises $30m for biomarker discovery program

MedGenomeGenomics research and diagnostics company MedGenome said today that it closed a $30 million Series C round led by Sequoia India and Sofina. Zodius Capital, the co-founder & former CEO of Infosys, Kris Gopalakrishnan, and former Cognizant CEO Lakshmi Narayanan also participated in the round.
- Source: drugdeliverybusiness
- 622
- August 30, 2017
genetic immunotherapy Market Views Series
Resonetics Acquires Aduro Laser, Adds Disruptive Manufacturing Capability for Laser Cut Tubing

Resonetics announced today its acquisition of Aduro Laser, an emerging leader in laser processing of tubular components for the medical device industry.
- Source: prnewswire
- 523
- August 29, 2017
acquisition Company Insight laser Market Views
Takeda partners to develop novel oncology therapies

Collaboration on an oncology drug discovery program was inked between Takeda Pharmaceutical, through its subsidiary Millennium Pharmaceuticals, and Molecular Templates.
- Source: drugdeliverybusiness
- 870
- August 28, 2017
Company Insight Market Views oncology therapy
Merck sees promise in Macrophage Pharma

Merck Ventures has become the latest group to invest in Macrophage Pharma and take a position on the UK biotech’s board of directors.
- Source: pharmatimes
- 641
- August 25, 2017
Clinical Market Views Merck
Patterson Dental, Align Technology sign distribution deal for intraoral scanning system

A distribution agreement for Align’s iTero Element intraoral scanning system has been signed between Patterson Dental, a business unit of Patterson Companies, and Align Technology.
- Source: medicaldevices-business-review
- 521
- August 25, 2017
Company Insight digital Market Views scanning
GlaxoSmithKline taking heat in its U.K. home turf over shortages of hepatitis B vaccine

GlaxoSmithKline is taking some heat at home over questions about global shortages of its and Merck’s hepatitis B vaccine that triggered rationing in the U.K., although GSK’s supplies to the much larger U.S. market seem to be unaffected.
- Source: fiercepharma
- 596
- August 24, 2017
hepatitis Market Views vaccine
NeoSync secures $13m in financing with Valiance Life Science Investments and current Investors

NeoSync has announced the completion of its Series D financing round, which included investment from Valiance Life Science Investments, as well as its original investor base totaling $13m.
- Source: patientmonitoring
- 608
- August 17, 2017
Clinical Depression Market Views Series
VentureMed raises $15m in Series B

Vascular focused device developer VentureMed said today it raised $15 million in a Series B round.
- Source: massdevice
- 510
- August 16, 2017
Company Insight Market Views medical device peripheral artery Series
NICE turns down kidney cancer drugs

It is looking unlikely that patients in England and Wales with advanced renal cell carcinoma will be getting routine NHS access to Eisai’s Kisplyx or Eusa Pharma’s Fotivda, after cost regulators issued draft guidelines turning down their use.
- Source: pharmatimes
- 527
- August 15, 2017
cancer kidney Market Views NHS renal

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.